Observational analysis reveals Lacticaseibacillus rhamnosus may improve hyperuricemia in metabolic disorder, suggesting a new treatment avenue.
Hyperuricemia is a growing metabolic disorder, whereas current microbiota-based strategies primarily focus on urate degradation or excretion, leaving upstream regulation of nucleoside precursors largely unexplored. Here, we isolated a nucleoside-degrading...
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: